SKYE:NASDAQSkye Bioscience, Inc. Analysis

Skye Bioscience, Inc. trades at $1.86, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. The last 30 days have lost 64.3%. Relative strength is 22.9 — oversold — and the MACD signal is bullish. Recent trading has carved out support near $1.64 and resistance around $7.04.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 3168.8% above the current price.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 109.1%, a beta of 1.04 and a maximum drawdown of 95.6%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.